Literature DB >> 10194475

Macrophages are a significant source of type 1 cytokines during mycobacterial infection.

J Wang1, J Wakeham, R Harkness, Z Xing.   

Abstract

T-helper 1 (Th1) cells are believed to be the major producer of the type 1 cytokine interferon-gamma (IFN-gamma) in cell-mediated immunity against intracellular infection. We have investigated the ability of macrophages to release type 1 cytokines and their regulatory mechanisms using both in vivo and in vitro models of pulmonary mycobacterial infection. During pulmonary infection by live Mycobacterium bovis bacilli Calmette-Guérin (BCG) in wild-type mice, lung macrophages released interleukin-12 (IL-12), IFN-gamma, and tumor necrosis factor-alpha (TNF-alpha), and expressed surface activation markers. However, macrophages in infected IL-12(-/-) mice released TNF-alpha but not IFN-gamma and lacked surface activation makers. In freshly isolated lung macrophages from naive IL-2(-/-) mice, mycobacteria alone released TNF-alpha but not IFN-gamma, whereas exogenously added IL-12 alone released a minimum of IFN-gamma. However, these macrophages released large quantities of IFN-gamma upon stimulation with both mycobacteria and IL-12. In contrast, mycobacteria and exogenous IFN-gamma released only a minimum of endogenous IFN-gamma. Endogenous IL-18 (IFN-gamma-inducing factor) played little role in IFN-gamma responses by macrophages stimulated by mycobacteria and IL-12. Our data reveal that macrophages are a significant source of type 1 cytokines during mycobacterial infection and that both IL-12 and intracellular pathogens are required for the release of IFN-gamma but not TNF-alpha. These findings suggest that macrophages regulate cell-mediated immunity by releasing not only IL-12 and TNF-alpha but also IFN-gamma and that full activation of IFN-gamma response in macrophages is tightly regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194475      PMCID: PMC408266          DOI: 10.1172/JCI6224

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  The expanding universe of T-cell subsets: Th1, Th2 and more.

Authors:  T R Mosmann; S Sad
Journal:  Immunol Today       Date:  1996-03

Review 2.  Regulation of interferon-gamma production by IL-12 and IL-18.

Authors:  H Okamura; S Kashiwamura; H Tsutsui; T Yoshimoto; K Nakanishi
Journal:  Curr Opin Immunol       Date:  1998-06       Impact factor: 7.486

3.  Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development.

Authors:  C A Wenner; M L Güler; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

Review 4.  Cytokines and pulmonary inflammatory and immune diseases.

Authors:  Z Xing; M Jordana; J Gauldie; J Wang
Journal:  Histol Histopathol       Date:  1999-01       Impact factor: 2.303

5.  Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

Authors:  J Bramson; M Hitt; W S Gallichan; K L Rosenthal; J Gauldie; F L Graham
Journal:  Hum Gene Ther       Date:  1996-02-10       Impact factor: 5.695

6.  Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  Z Xing; J Wang; K Croitoru; J Wakeham
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guérin in IL-12-deficient mice.

Authors:  J Wakeham; J Wang; J Magram; K Croitoru; R Harkness; P Dunn; A Zganiacz; Z Xing
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

8.  Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation.

Authors:  M Munder; M Mallo; K Eichmann; M Modolell
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

9.  Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.

Authors:  E von Stebut; Y Belkaid; T Jakob; D L Sacks; M C Udey
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  62 in total

Review 1.  Toll-like receptors: molecular mechanisms of the mammalian immune response.

Authors:  H D Brightbill; R L Modlin
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

2.  Cytokine expression profiles of bovine lymph nodes: effects of Mycobacterium bovis infection and bacille Calmette-Guérin vaccination.

Authors:  S Widdison; L J Schreuder; B Villarreal-Ramos; C J Howard; M Watson; T J Coffey
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

3.  Influence of the tissue microenvironment on Toll-like receptor expression by CD11c+ antigen-presenting cells isolated from mucosal tissues.

Authors:  Shunsuke Takenaka; Sarah McCormick; Ekaterina Safroneeva; Zhou Xing; Jack Gauldie
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

4.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

5.  Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Authors:  Leah E Cole; Barbara J Mann; Kari Ann Shirey; Katharina Richard; Yang Yang; Patricia J Gearhart; Kirsty L Chesko; Rose M Viscardi; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2011-07-12       Impact factor: 4.962

6.  Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.

Authors:  Lihao Chen; Jun Wang; Anna Zganiacz; Zhou Xing
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

8.  Immunosuppressive properties of Pluchea lanceolata leaves.

Authors:  D P Bhagwat; M D Kharya; Sarang Bani; Anpurna Kaul; Kiranjeet Kour; Prashant Singh Chauhan; K A Suri; N K Satti
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

Review 9.  Mycobacterium bovis bacillus Calmette-Guérin-induced macrophage cytotoxicity against bladder cancer cells.

Authors:  Yi Luo; Matthew J Knudson
Journal:  Clin Dev Immunol       Date:  2010-09-01

10.  Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection.

Authors:  Naoko Aoki; Anna Zganiacz; Peter Margetts; Zhou Xing
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.